Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer drugs
Research
Infinity Pharma cancer drug stops COVID, MRSA damage in mice
New findings in mice show that an experimental cancer drug developed by a now-bankrupt biotech can suppress a key driver of lung inflammation.
Helen Floersh
Jul 9, 2024 7:00am
ASCO: It's back to the basics for cancer drug developers
Jun 5, 2024 10:55am
Clinical-stage cancer biotech Actuate latest to eye summer IPO
May 28, 2024 9:45am
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
Prelude thinks SMARCA with AbCellera deal, culls 2 candidates
Nov 2, 2023 8:06am
Ariceum bolsters radiopharma efforts with Theragnostics buy
Jun 1, 2023 10:35am